Market Cap 10.33M
Revenue (ttm) 1.53M
Net Income (ttm) -93.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,107.19%
Debt to Equity Ratio 0.00
Volume 17,400
Avg Vol 28,564
Day's Range N/A - N/A
Shares Out 1.65M
Stochastic %K 11%
Beta 0.11
Analysts Hold
Price Target $11.50

Company Profile

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhi...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 393 4600
Address:
480 Arsenal Way, Watertown, United States
EF5Stocks
EF5Stocks Oct. 25 at 9:46 PM
$LYRA 10.5M market cap for a Ph3 is diabolical IMO.
0 · Reply
EF5Stocks
EF5Stocks Oct. 21 at 5:28 PM
$LYRA I believe this could be like $NERV or $RANI if they close a private placement to fund the third Phase 3 Enlighten trial. They really need to look for private equity to fund it or perhaps a big pharma partnership.
1 · Reply
EF5Stocks
EF5Stocks Oct. 17 at 10:58 PM
$LYRA IMO 11M market cap for a biotech with a Phase 3 asset that already completed one successful trial is diabolical. How is this so undervalued?
1 · Reply
Akbigd
Akbigd Oct. 12 at 6:09 AM
$LYRA LYRA low float (1.12M), low OS (1.64M) biotech w/ Phase 3 asset for rhino sinusitis. Cash runway into 2026. Former runner to near 40. Market cap < 15M
1 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 9:59 PM
$QNRX Like this one and $LYRA both biotech and somewhat tariff proof.
0 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 6:29 PM
$LYRA Hopefully they will look for a private placement like $QNRX or $SPRB to fund the next trial. Great results from earlier Enlighten trials.
0 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 5:55 PM
$LYRA 1.64M OS 1.12M Float; cash runway into 2026 w/ active Phase 3 asset. Market Cap < 15M. Undervalued. Reminds me of $SPRB
0 · Reply
Akbigd
Akbigd Oct. 10 at 3:35 AM
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:44 PM
Keep a close watch on CMCT! $TAOP $LYRA $ASPS $PLRZ 77
0 · Reply
Akbigd
Akbigd Oct. 9 at 3:22 AM
$LYRA small float bio worth watching w/ Phase 3 assets and sub 15M market cap. 1.64M OS; 1.12M float
0 · Reply
Latest News on LYRA
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?

Jun 2, 2025, 8:29 AM EDT - 5 months ago

Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?


3 'Buy-Rated' Biotech Stocks Under $10

Apr 28, 2024, 4:39 AM EDT - 1 year ago

3 'Buy-Rated' Biotech Stocks Under $10

ADMA GERN


Lyra Therapeutics: Hold For Phase 3 Topline

Oct 10, 2023, 10:56 AM EDT - 2 years ago

Lyra Therapeutics: Hold For Phase 3 Topline


Lyra Therapeutics Announces $50.0 Million Private Placement

May 26, 2023, 7:57 AM EDT - 2 years ago

Lyra Therapeutics Announces $50.0 Million Private Placement


Lyra Therapeutics to Present at Upcoming Investor Conferences

May 26, 2022, 7:00 AM EDT - 3 years ago

Lyra Therapeutics to Present at Upcoming Investor Conferences


EF5Stocks
EF5Stocks Oct. 25 at 9:46 PM
$LYRA 10.5M market cap for a Ph3 is diabolical IMO.
0 · Reply
EF5Stocks
EF5Stocks Oct. 21 at 5:28 PM
$LYRA I believe this could be like $NERV or $RANI if they close a private placement to fund the third Phase 3 Enlighten trial. They really need to look for private equity to fund it or perhaps a big pharma partnership.
1 · Reply
EF5Stocks
EF5Stocks Oct. 17 at 10:58 PM
$LYRA IMO 11M market cap for a biotech with a Phase 3 asset that already completed one successful trial is diabolical. How is this so undervalued?
1 · Reply
Akbigd
Akbigd Oct. 12 at 6:09 AM
$LYRA LYRA low float (1.12M), low OS (1.64M) biotech w/ Phase 3 asset for rhino sinusitis. Cash runway into 2026. Former runner to near 40. Market cap < 15M
1 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 9:59 PM
$QNRX Like this one and $LYRA both biotech and somewhat tariff proof.
0 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 6:29 PM
$LYRA Hopefully they will look for a private placement like $QNRX or $SPRB to fund the next trial. Great results from earlier Enlighten trials.
0 · Reply
EF5Stocks
EF5Stocks Oct. 10 at 5:55 PM
$LYRA 1.64M OS 1.12M Float; cash runway into 2026 w/ active Phase 3 asset. Market Cap < 15M. Undervalued. Reminds me of $SPRB
0 · Reply
Akbigd
Akbigd Oct. 10 at 3:35 AM
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:44 PM
Keep a close watch on CMCT! $TAOP $LYRA $ASPS $PLRZ 77
0 · Reply
Akbigd
Akbigd Oct. 9 at 3:22 AM
$LYRA small float bio worth watching w/ Phase 3 assets and sub 15M market cap. 1.64M OS; 1.12M float
0 · Reply
EF5Stocks
EF5Stocks Oct. 8 at 5:42 PM
$LYRA interesting here prior runner from 4/5 to 38 and active assets in Phase 3 w/ market cap under 15M--look at other small float bios $SPRB $GLTO $XBIO $ATON
0 · Reply
Akbigd
Akbigd Oct. 8 at 5:20 PM
0 · Reply
WoldanStanford
WoldanStanford Oct. 8 at 11:22 AM
0 · Reply
TA_Kongen
TA_Kongen Oct. 7 at 10:48 PM
$ACXP $BDRX $ONCO $LYRA $SLRX Potential bio movers here. All on watch.
0 · Reply
Akbigd
Akbigd Oct. 6 at 7:14 PM
$LYRA low Floater 1.6mill float with 12million Market Cap. It can run for day
0 · Reply
Akbigd
Akbigd Oct. 6 at 7:13 PM
$LYRA about to Pump Soon, NDA Submission Soon
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 6 at 6:35 PM
Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate $LYRA $DFAS $VTI https://stocktwits.com/news/equity/markets/lyra-therapeutics-to-conduct-one-more-trial-for-chronic-rhinosinusitis-treatment-candidate/ch6RXopR3gx
0 · Reply
kshonstocks
kshonstocks Oct. 6 at 6:32 PM
heres one that looks promising $LYRA perceptive is top holder had gd news this morning Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study - Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission - 1 for50 split back in May
1 · Reply
Rjinvestments88
Rjinvestments88 Oct. 6 at 6:25 PM
$SPRB ok had to cut 3/4 position been holding for long time for this now out using profits in a few will be 👀 $LYRA With low float and insider bought nice amount before R/S and dint sell held nice bottom around 6s may hear some big news here as well also May add to my $UNH have average 302 nice dividend play with things clearing up
0 · Reply
Rjinvestments88
Rjinvestments88 Oct. 6 at 6:21 PM
$CLNN low float seems news may be coming same as for $LYRA Low float after r/s while back and has very low marketcap that looks like has alot of room to run 👀
0 · Reply
Akbigd
Akbigd Oct. 6 at 1:41 PM
0 · Reply
FrozenFib
FrozenFib Oct. 5 at 11:01 AM
$LYRA Biotech with clinical catalyst. High short interest. Volatility compression suggests large move imminent. High risk setup.
0 · Reply